Published in Gastroenterology on March 06, 2006
Classification of premalignant pancreatic cancer mass-spectrometry data using decision tree ensembles. BMC Bioinformatics (2008) 1.01
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis. Br J Cancer (2010) 0.97
Proteomics portrait of archival lesions of chronic pancreatitis. PLoS One (2011) 0.93
Diagnostic and prognostic biomarkers in pancreatic carcinoma. Int J Clin Exp Pathol (2008) 0.85
Sporadic pancreatic polypeptide secreting tumors (PPomas) of the pancreas. World J Surg (2008) 0.83
Tissue biomarkers of breast cancer and their association with conventional pathologic features. Br J Cancer (2013) 0.81
The current state of proteomics in GI oncology. Dig Dis Sci (2008) 0.81
Simpler evaluation of predictions and signature stability for gene expression data. J Biomed Biotechnol (2010) 0.78
Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma in China: a SELDI-TOF-MS study. Int J Clin Exp Pathol (2008) 0.75
A proteomic analysis of Curcuma comosa Roxb. rhizomes. Proteome Sci (2011) 0.75
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev (2002) 6.43
Multimodal analgesia and intravenous nutrition preserves total body protein following major upper gastrointestinal surgery. Reg Anesth Pain Med (2002) 2.60
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. J Clin Oncol (2013) 2.26
Efficient experimental design and analysis strategies for the detection of differential expression using RNA-Sequencing. BMC Genomics (2012) 2.19
The glycemic index of foods influences postprandial insulin-like growth factor-binding protein responses in lean young subjects. Am J Clin Nutr (2005) 1.75
Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am J Surg Pathol (2010) 1.73
Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity (2004) 1.57
Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis. J Hepatol (2002) 1.57
Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping tests. Clin Chem (2008) 1.55
Grafts for mesenterico-portal vein resections can be avoided during pancreatoduodenectomy. J Am Coll Surg (2012) 1.52
Pyogenic liver abscess: an audit of 10 years' experience. World J Gastroenterol (2011) 1.51
Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. J Clin Endocrinol Metab (2004) 1.50
Statistical analysis of adsorption models for oligonucleotide microarrays. Stat Appl Genet Mol Biol (2004) 1.45
Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem (2003) 1.43
RSV604, a novel inhibitor of respiratory syncytial virus replication. Antimicrob Agents Chemother (2007) 1.34
Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology (2009) 1.23
Objective determination of appropriate reporting intervals. Ann Clin Biochem (2004) 1.23
Rapamycin treatment for a child with germline PTEN mutation. Nat Clin Pract Oncol (2008) 1.21
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. J Urban Health (2008) 1.18
Intrapancreatic splenunculus. Am J Surg (2007) 1.16
Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2. J Clin Endocrinol Metab (2003) 1.15
The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) (2002) 1.11
Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. Hepatology (2006) 1.10
IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology (2002) 1.07
Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability. J Clin Endocrinol Metab (2010) 1.07
Modified extended pancreatoduodenectomy: en bloc resection of the peripancreatic retroperitoneal tissue and the head of pancreas. ANZ J Surg (2006) 1.07
Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes. J Clin Endocrinol Metab (2005) 1.06
Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. Am J Physiol Endocrinol Metab (2009) 1.06
Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling. J Clin Endocrinol Metab (2004) 1.05
Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. J Biol Chem (2002) 1.05
Visualisation of gene expression data - the GE-biplot, the Chip-plot and the Gene-plot. Stat Appl Genet Mol Biol (2003) 1.05
Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells. Endocrinology (2005) 1.04
Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. J Biol Chem (2009) 1.04
Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab (2002) 1.02
Characterizing the D2 statistic: word matches in biological sequences. Stat Appl Genet Mol Biol (2009) 1.02
Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. J Biol Chem (2001) 1.00
Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase). Invest Ophthalmol Vis Sci (2011) 1.00
Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis. Cancer Res (2006) 0.99
The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor. Endocr Relat Cancer (2010) 0.99
Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma. Pancreas (2008) 0.99
Novel biomarkers of human growth hormone action from serum proteomic profiling using protein chip mass spectrometry. J Clin Endocrinol Metab (2005) 0.99
SeqVis: visualization of compositional heterogeneity in large alignments of nucleotides. Bioinformatics (2006) 0.98
Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer. Breast Cancer Res (2014) 0.98
Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. J Clin Endocrinol Metab (2004) 0.98
Impairment of organ-specific T cell negative selection by diabetes susceptibility genes: genomic analysis by mRNA profiling. Genome Biol (2007) 0.98
Focal nodular hyperplasia--a review of myths and truths. J Gastrointest Surg (2011) 0.97
Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Endocrinology (2007) 0.96
Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells. Biochem Biophys Res Commun (2004) 0.95
1,4-benzodiazepines as inhibitors of respiratory syncytial virus. The identification of a clinical candidate. J Med Chem (2007) 0.95
Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma. Pathology (2009) 0.95
Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma. J Urol (2008) 0.95
Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells. Endocr Relat Cancer (2013) 0.94
Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade. Mol Cancer Ther (2013) 0.94
Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL. J Proteome Res (2011) 0.93
Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression. Mod Pathol (2012) 0.91
Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. PLoS One (2012) 0.91
Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: role in modulation of RAR-signaling. Arch Biochem Biophys (2007) 0.91
Peripancreatic pseudoaneurysms: a management-based classification system. Surg Endosc (2014) 0.90
Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation. Endocrinology (2003) 0.90
Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3. Growth Factors (2011) 0.90
Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Int J Biochem Cell Biol (2009) 0.90
Assessment of HER-2 status in pancreatic adenocarcinoma: correlation of immunohistochemistry, quantitative real-time RT-PCR, and FISH with aneuploidy and survival. Am J Surg Pathol (2005) 0.90
1,4-Benzodiazepines as inhibitors of respiratory syncytial virus. J Med Chem (2006) 0.90
Effect of maternal asthma, inhaled glucocorticoids and cigarette use during pregnancy on the newborn insulin-like growth factor axis. Growth Horm IGF Res (2009) 0.89
Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. Mol Endocrinol (2007) 0.89
Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction. J Gastroenterol Hepatol (2005) 0.88
Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays. Expert Rev Proteomics (2012) 0.88
Alignment-free sequence comparison for biologically realistic sequences of moderate length. Stat Appl Genet Mol Biol (2012) 0.88
Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation. J Biol Chem (2004) 0.88
Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes. J Clin Endocrinol Metab (2008) 0.87
Activity of human pregnancy insulin-like growth factor binding protein-3: determination by reconstituting recombinant complexes. Endocrinology (2009) 0.87
Insulin-like growth factor binding protein-3 inhibits migration of endometrial cancer cells. Cancer Lett (2011) 0.87
Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure. HPB (Oxford) (2010) 0.87
The aminoterminal insulin-like growth factor (IGF) binding domain of IGF binding protein-3 cannot be functionally substituted by the structurally homologous domain of CCN3. Endocrinology (2006) 0.87
Impaired blockade of insulin-like growth factor I (IGF-I)-induced hypoglycemia by IGF binding protein-3 analog with reduced ternary complex-forming ability. Endocrinology (2002) 0.87
Hemosuccus pancreaticus. ANZ J Surg (2004) 0.86
Optimizing microarray in experimental hypertension. Kidney Int (2005) 0.86
Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions. Endocrinology (2003) 0.86
Gonadotropin signalling in epithelial ovarian cancer. Cancer Lett (2012) 0.86
Clinical and pathologic features of familial pancreatic cancer. Cancer (2014) 0.86
TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells. Mol Cell Endocrinol (2013) 0.86
Growth hormone rapidly induces resistin gene expression in white adipose tissue of spontaneous dwarf (SDR) rats. Endocrinology (2002) 0.85
Proteomic profiling of growth hormone-responsive proteins in human peripheral blood leukocytes. J Clin Endocrinol Metab (2009) 0.85
The role of minimally invasive percutaneous embolisation technique in the management of bleeding stomal varices. J Gastrointest Surg (2013) 0.84
Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line. Am J Respir Cell Mol Biol (2002) 0.84
Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets. BMC Genomics (2007) 0.83
Classification of pancreatic cystic lesions using SELDI-TOF mass spectrometry. ANZ J Surg (2007) 0.83
Sporadic pancreatic polypeptide secreting tumors (PPomas) of the pancreas. World J Surg (2008) 0.83
Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. Int J Oncol (2005) 0.83
Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C{delta}. Endocr Relat Cancer (2010) 0.83
An efficient Z-score algorithm for assessing sequence alignments. J Comput Biol (2004) 0.82